Flagship Pioneering Fund VII General Partner LLC

Insider Reports History

Entity
Company
Location
55 Cambridge Parkway, 8 Th Floor, Cambridge, MA
Signature
Flagship Pioneering Fund VII General Partner LLC, By: Flagship Pioneering, Inc., its manager, By: /s/ Noubar B. Afeyan, PhD., Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Flagship Pioneering Fund VII General Partner LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. 10%+ Owner Common Stock 1.33M $10.6M $8.00 Feb 27, 2023 By Flagship Pioneering Fund VII, L.P.
Seres Therapeutics, Inc. 10%+ Owner Common Stock 5.83M $7.86M $1.35 Jul 5, 2022 By Flagship Pioneering Fund VII, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 13.7M $4.52M $0.33 May 27, 2022 By Flagship Pioneering Fund VII, L.P.

Insider Reports Filed by Flagship Pioneering Fund VII General Partner LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. May 22, 2024 0 $0 3 May 24, 2024 10%+ Owner
SANA Sana Biotechnology, Inc. Feb 12, 2024 0 $0 3 Feb 14, 2024 10%+ Owner
OMGA Omega Therapeutics, Inc. Feb 27, 2023 0 $0 3 Feb 27, 2023 10%+ Owner
MCRB Seres Therapeutics, Inc. Jul 5, 2022 0 $0 3 Jul 7, 2022 10%+ Owner
EVLO Evelo Biosciences, Inc. May 27, 2022 0 $0 3 Jun 1, 2022 10%+ Owner